CAPTRUST Financial Advisors’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
2023
Q1
$27.1K Buy
2022
Q4
Sell
2022
Q3
$83K Buy
2022
Q2
$68K Sell
2022
Q1
$166K Hold
2021
Q4
$205K Hold
2021
Q3
$182K Hold
2021
Q2
$167K Buy
2021
Q1
$221K Buy
2020
Q4
$80K Buy
2020
Q3
$99K Hold
2020
Q2
$73K Buy